Literature DB >> 3722337

A statistical method for assessing change in immunologic parameters in a patient.

J M Taylor, S Plaeger-Marshall, J L Fahey.   

Abstract

Serial measurement of in vitro immunologic parameters in patients is used to detect change in immune status over time due to disease progression and/or immunodulatory therapy. A statistical method is presented for looking at serial measurements on an individual to detect whether a change in a parameter is outside the bounds of expected within-individual variation. Analysis of variance is used, assuming a normal distribution, to obtain percentiles of the distribution of the absolute difference between consecutive values of immunologic parameters in a healthy population. The assumptions in this analysis are justified from a statistical point of view. We discuss how to use this statistical method to make judgments relevant to clinical immunology, including how to construct a table that can be used to determine quickly if an "interesting" change for some standard immunologic parameters has occurred, whether a linear (additive) or logarithmic (proportional) model for change might be more appropriate for a given parameter, and how to modify the calculations if change is expected in a certain direction or if multiple pre- and/or postevent (clinical change or intervention) measurements are available.

Entities:  

Mesh:

Year:  1986        PMID: 3722337     DOI: 10.1007/bf00918705

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  5 in total

1.  Prognostically significant classification of immune changes in AIDS with Kaposi's sarcoma.

Authors:  J Taylor; R Afrasiabi; J L Fahey; E Korns; M Weaver; R Mitsuysau
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

2.  Growth rates of mixed leukocyte cultures.

Authors:  D W Alling; B D Kahan
Journal:  Transplantation       Date:  1969-07       Impact factor: 4.939

3.  Relation between sexual practices and T-cell subsets in homosexually active men.

Authors:  R Detels; J L Fahey; K Schwartz; R S Greene; B R Visscher; M S Gottlieb
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

4.  Immunological changes in lymphadenopathy virus positive and negative symptomless male homosexuals: two years of observation.

Authors:  K Schwartz; B R Visscher; R Detels; J Taylor; P Nishanian; J L Fahey
Journal:  Lancet       Date:  1985-10-12       Impact factor: 79.321

5.  The use of three baseline values in intervention studies: application to evaluation of immune modulation therapies.

Authors:  E L Korn; F Dorey; C A Spina; J L Fahey
Journal:  Immunobiology       Date:  1984-12       Impact factor: 3.144

  5 in total
  1 in total

1.  Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression.

Authors:  E Ojo-Amaize; P G Nishanian; D F Heitjan; A Rezai; I Esmail; E Korns; R Detels; J Fahey; J V Giorgi
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.